The mRNA expression levels of estrogen receptor α (ERα), estrogen receptor β (ERβ), and progesterone receptor (PR) were significantly up-regulated in leiomyomas that were treated with GnRHa. The gene discussed is ESR1; the disease is leiomyoma.